Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Angiotensin-converting enzyme inhibitors in the treatment of hypertension.

× No keyword cloud information.

16 in total

1. Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade.

Authors: J A Lopez-Ovejero; S D Saal; W A D'Angelo; J S Cheigh; K H Stenzel; J H Laragh
Journal: N Engl J Med Date: 1979-06-21 Impact factor: 91.245

2. Hemodialysis-resistant hypertension: control with an orally active inhibitor of angiotensin-converting enzyme.

Authors: E D Vaughan; R M Carey; C R Ayers; M J Peach
Journal: J Clin Endocrinol Metab Date: 1979-05 Impact factor: 5.958

3. Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor.

Authors: J H Laragh; D B Case; S A Atlas; J E Sealey
Journal: Hypertension Date: 1980 Jul-Aug Impact factor: 10.190

4. Treatment of hypertension with angiotensin converting enzyme inhibitors.

Authors: C I Johnston; B P McGrath; P G Matthews; B Jackson
Journal: Clin Exp Pharmacol Physiol Suppl Date: 1982

5. The development of captopril and its role in the treatment of hypertension.

Authors: J R Knill
Journal: Clin Exp Pharmacol Physiol Suppl Date: 1982

Review 6. Medical intelligence drug therapy: captopril.

Authors: D G Vidt; E L Bravo; F M Fouad
Journal: N Engl J Med Date: 1982-01-28 Impact factor: 91.245

7. Clinical use of an orally acting converting enzyme inhibitor: captopril.

Authors: H R Brunner; H Gavras; B Waeber; S C Textor; G A Turini; J P Wauters
Journal: Hypertension Date: 1980 Jul-Aug Impact factor: 10.190

8. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

Authors: M A Ondetti; B Rubin; D W Cushman
Journal: Science Date: 1977-04-22 Impact factor: 47.728

Review 9. Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors: R C Heel; R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1980-12 Impact factor: 9.546

10. Use of captopril in the diagnosis of renal hypertension.

Authors: B P McGrath; P G Matthews; C I Johnston
Journal: Aust N Z J Med Date: 1981-08

13 in total

Review 1. Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?

Authors: D A Sica
Journal: Drugs Date: 1994-07 Impact factor: 9.546

Review 2. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.

Authors: Domenic A Sica
Journal: Drugs Date: 2002 Impact factor: 9.546

Review 3. Angiotensin converting enzyme inhibitors.

Authors: A Breckenridge
Journal: Br Med J (Clin Res Ed) Date: 1988-02-27

Review 4. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors: R I Henkin
Journal: Drug Saf Date: 1994-11 Impact factor: 5.606

5. Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease.

Authors: S Krähenbühl; P Grass; A Surve; K Kutz; J Reichen
Journal: Eur J Clin Pharmacol Date: 1993 Impact factor: 2.953

Review 6. Rationale for combination therapy.

Authors: L Hansson
Journal: Br J Clin Pharmacol Date: 1987 Impact factor: 4.335

Angiotensin-converting enzyme inhibitors in the treatment of hypertension.